Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myocardial Metabolic Flux in PAH in Response to GLP-1 Agonist Therapy
NCT07737522Phase 2Not yet recruiting
- Sponsor
- Imperial College London
- Start
- Oct 2026
- Primary completion
- Oct 2028
01
Overview
A Phase 2 trial of semaglutide in pulmonary arterial hypertension (PAH), sponsored by Imperial College London. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on NCT07737522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07737522.